A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
- Author
- POLMAN, Chris H1 ; O'CONNOR, Paul W2 ; TOAL, Martin10 ; LYNN, Frances10 ; PANZARA, Michael A10 ; SANDROCK, Alfred W10 ; HAVRDOVA, Eva3 ; HUTCHINSON, Michael4 ; KAPPOS, Ludwig5 ; MILLER, David H6 ; PHILLIPS, J. Theodore7 ; LUBLIN, Fred D8 ; GIOVANNONI, Gavin6 ; WAJGT, Andrzej9
[1] Vrije Universiteit Medical Center, Amsterdam, Netherlands
[2] St. Michael's Hospital, Toronto, Canada
[3] General Teaching Hospital, Prague, Czech Republic
[4] St. Vincent's University Hospital, Dublin, Ireland
[5] University Hospital Basel, Basel, Switzerland
[6] Institute of Neurology, London, United Kingdom
[7] Texas Neurology, Dallas, United States
[8] Mt. Sinai School of Medicine, New York, United States
[9] Silesian Medical University, Katowice, Poland
[10] Biogen Idec, Cambridge, Mass, United States
AFFIRM Investigators - Source
The New England journal of medicine. 2006, Vol 354, Num 9, pp 899-910, 12 p ; ref : 29 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Boston, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Essai clinique Immunomodulateur Médecine Natalizumab Placebo Randomisation Récidive Sclérose en plaques Essai randomisé contrôlé Anticorps monoclonal Maladie inflammatoire Système nerveux central pathologie Système nerveux pathologie
- Keyword (en)
- Clinical trial Immunomodulator Medicine Natalizumab Placebo Randomization Relapse Multiple sclerosis Randomised controlled trial Monoclonal antibody Inflammatory disease Central nervous system disease Nervous system diseases
- Keyword (es)
- Ensayo clínico Inmunomodulador Medicina Natalizumab Placebo Aleatorización Recaida Esclerosis en placa Ensayo clínico aleatorio Anticuerpo monoclonal Enfermedad inflamatoria Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Discipline
- Generalities in medical sciences Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17556331
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa044397 
https://dx.doi.org/10.1056/NEJMoa044397
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"910\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"POLMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Chris H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:16:\"O'CONNOR, Paul W\";i:1;s:12:\"TOAL, Martin\";i:2;s:13:\"LYNN, Frances\";i:3;s:18:\"PANZARA, Michael A\";i:4;s:18:\"SANDROCK, Alfred W\";i:5;s:13:\"HAVRDOVA, Eva\";i:6;s:19:\"HUTCHINSON, Michael\";i:7;s:14:\"KAPPOS, Ludwig\";i:8;s:15:\"MILLER, David H\";i:9;s:21:\"PHILLIPS, J. Theodore\";i:10;s:14:\"LUBLIN, Fred D\";i:11;s:17:\"GIOVANNONI, Gavin\";i:12;s:14:\"WAJGT, Andrzej\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"910\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"POLMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Chris H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:16:\"O'CONNOR, Paul W\";i:1;s:12:\"TOAL, Martin\";i:2;s:13:\"LYNN, Frances\";i:3;s:18:\"PANZARA, Michael A\";i:4;s:18:\"SANDROCK, Alfred W\";i:5;s:13:\"HAVRDOVA, Eva\";i:6;s:19:\"HUTCHINSON, Michael\";i:7;s:14:\"KAPPOS, Ludwig\";i:8;s:15:\"MILLER, David H\";i:9;s:21:\"PHILLIPS, J. Theodore\";i:10;s:14:\"LUBLIN, Fred D\";i:11;s:17:\"GIOVANNONI, Gavin\";i:12;s:14:\"WAJGT, Andrzej\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"910\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"POLMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Chris H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:16:\"O'CONNOR, Paul W\";i:1;s:12:\"TOAL, Martin\";i:2;s:13:\"LYNN, Frances\";i:3;s:18:\"PANZARA, Michael A\";i:4;s:18:\"SANDROCK, Alfred W\";i:5;s:13:\"HAVRDOVA, Eva\";i:6;s:19:\"HUTCHINSON, Michael\";i:7;s:14:\"KAPPOS, Ludwig\";i:8;s:15:\"MILLER, David H\";i:9;s:21:\"PHILLIPS, J. Theodore\";i:10;s:14:\"LUBLIN, Fred D\";i:11;s:17:\"GIOVANNONI, Gavin\";i:12;s:14:\"WAJGT, Andrzej\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"910\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"POLMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Chris H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:16:\"O'CONNOR, Paul W\";i:1;s:12:\"TOAL, Martin\";i:2;s:13:\"LYNN, Frances\";i:3;s:18:\"PANZARA, Michael A\";i:4;s:18:\"SANDROCK, Alfred W\";i:5;s:13:\"HAVRDOVA, Eva\";i:6;s:19:\"HUTCHINSON, Michael\";i:7;s:14:\"KAPPOS, Ludwig\";i:8;s:15:\"MILLER, David H\";i:9;s:21:\"PHILLIPS, J. Theodore\";i:10;s:14:\"LUBLIN, Fred D\";i:11;s:17:\"GIOVANNONI, Gavin\";i:12;s:14:\"WAJGT, Andrzej\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa044397\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"354\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:3:\"899\";s:8:\"\u0000*\u0000epage\";s:3:\"910\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"POLMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Chris H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:16:\"O'CONNOR, Paul W\";i:1;s:12:\"TOAL, Martin\";i:2;s:13:\"LYNN, Frances\";i:3;s:18:\"PANZARA, Michael A\";i:4;s:18:\"SANDROCK, Alfred W\";i:5;s:13:\"HAVRDOVA, Eva\";i:6;s:19:\"HUTCHINSON, Michael\";i:7;s:14:\"KAPPOS, Ludwig\";i:8;s:15:\"MILLER, David H\";i:9;s:21:\"PHILLIPS, J. Theodore\";i:10;s:14:\"LUBLIN, Fred D\";i:11;s:17:\"GIOVANNONI, Gavin\";i:12;s:14:\"WAJGT, Andrzej\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
